VIM and melanoma: Canonical CAF markers also have different functions in these cancers; for example, aSMA can be expressed by basal cells in the breast, while vimentin is frequently expressed by melanoma cells and is associated with poor prognosis (Mumcuoglu et al., 2010; Novotný et al., 2020).